Free Oncology CME 2017‑2018 | CMEList.com

 


High Suspicion of Lung Cancer: Setting the Stage with a Good Biopsy Free Lung Cancer CME
Posted by...Bernard Sklar, MD.
Free Pulmonology CME Credit hours...0.5. 
CME Credits Awarded by....The France Foundation
Cost...........Free.
Instruction Type...Slide-Video Lecture.
Target Audiences...This program is intended for pulmonologists, critical care clinicians and other healthcare professionals involved in the management of patients with NSCLC.
Educational material updated....November 18, 2016.
Expiration of CME credit...November 17, 2017.
Financial Support...Bristol-Myers Squibb.
Dr. Momen Wahidi and Dr. W. Dean Wallace discuss how molecular diagnostics and targeted therapy rely on adequate tissue biopsy.
Upon completion of High Suspicion of Lung Cancer: Setting the Stage with a Good Biopsy, you should be able to:
• Identify key aspects of current guidance pertaining to adequate tissue acquisition and its implications in NSCLC
• Recognize the importance of obtaining adequate tissue samples for NSCLC diagnosis and classification, including molecular analysis

Work-Up of a Patient with Right Upper Lobe Mass and Metastases Free Lung Cancer CME
Posted by...Bernard Sklar, MD.
Free Pulmonology CME Credit hours...0.5. 
CME Credits Awarded by....The France Foundation.
Cost...........Free.
Instruction Type...Slide-Video Lecture.
Target Audiences...This program is intended for pulmonologists, critical care clinicians and other healthcare professionals involved in the management of patients with NSCLC.
Educational material updated....November 18, 2016.
Expiration of CME credit...November 17, 2017.
Financial Support...Bristol-Myers Squibb.
W. Dean Wallace, MD and Dr. Momen Wahidi discuss tissue processing and analysis from the pathology perspective.
Upon completion of Work-Up of a Patient with Right Upper Lobe Mass and Metastases, you should be able to:
• Identify key aspects of current guidance pertaining to adequate tissue acquisition and its implications in NSCLC
• Recognize the importance of obtaining adequate tissue samples for NSCLC diagnosis and classification, including molecular analysis

New Horizons in the Management of Metastatic Pancreatic Cancer
Free Pancreatic Cancer CME Live online February 15, 2017, and available on demand through August 15, 2017.
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit hours...1.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists, gastroenterologists, and other health care professionals (primary care physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved or interested in the management of patients with pancreatic cancer.
Educational material updated... February 15, 2017.
Expiration of CME credit...August 15, 2017.
Financial Support...Incyte Corporation.
This activity consists of a single lecture, New Horizons in the Management of Metastatic Pancreatic Cancer, with discussion. At the conclusion of New Horizons in the Management of Metastatic Pancreatic Cancer, you will be able to:
• Examine the safety and efficacy data of emerging and available treatment options for patients with metastatic pancreatic cancer
• Evaluate and select optimal treatment algorithms for patients with metastatic pancreatic cancer

Metastatic Colorectal Cancer: Decoding Complex Treatment Algorithms through Debates and Cases Free Colorectal Cancer CME
This presentation is in two parts: The first part, Treatment Controversies in Metastatic Colorectal Cancer, live online December 16, 2016, and available on demand through July 31, 2017.
The second part, Examining Clinical Cases in Metastatic Colorectal Cancer, live online January 31, 2017, and available on demand through July 31, 2017.
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit hours...2.0. 
CME Credits Awarded by....University of Nebraska Medical Center.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists and other health care professionals (physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved or interested in the therapeutic management of patients with metastatic colorectal cancer (CRC).
Educational material updated....December 16, 2016.
Expiration of CME credit...July 31, 2017.
Financial Support...Genentech, Inc., Taiho Oncology, Inc, and Lilly.
Financial Support...Merck.
After viewing Metastatic Colorectal Cancer,  you will be better able to:
• Examine the latest safety and efficacy data of available treatments in the first, second, and beyond lines for metastatic CRC
• Compare the benefits and challenges among available CRC treatments in first-, second-, and third-line settings
• Summarize the key results from the abstracts presented at the 2017 Gastrointestinal Cancers Symposium (ASCO GI)
• Evaluate and select optimal treatment algorithms for patients with metastatic CRC
• Appraise the emerging application of immunotherapy for metastatic CRC

Myeloproliferative Disorders: Improving Outcomes for Patients with Myeloproliferative Disorders Free Myeloproliferative Disorders CME
Live online October 27, 2016, and available on demand through October 27, 2017.
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit hours...2.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for hematologists, medical oncologists, oncology nurses, pharmacists, and other clinicians involved in the diagnosis and treatment of chronic myeloid leukemia (CML) and myeloproliferative neoplasms.
Educational material updated... October 27, 2016.
Expiration of CME credit...October 27, 2017.
Financial Support...Incyte Corporation.
Improving Outcomes for Patients with Myeloproliferative Disorders consists of two lectures:
• Updates in Chronic Phase Chronic Myeloid Leukemia; and
• Addressing The Challenges in Myeloproliferative Neoplasms
After viewing these two presentations you will be better able to:
• Implement evidence-based recommendations for molecular profiling, monitoring of treatment response, and managing tyrosine kinase inhibitor resistance.
• Employ new data on the safety and efficacy of current and emerging agents and combinations, mechanisms of action, molecular targets, and routes of administration to improve CML patient outcomes.

Lung Immunotherapies: Shifting the Lung Cancer Treatment Paradigm
Live online November 3, 2016, and available on demand through May 3, 2017.
Posted by...Bernard Sklar, MD.Lung Cancer CME
Free Oncology CME Credit hours...1.0. 
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists, oncology nurses, nurse practitioners, physician assistants, primary care physicians, pulmonologists, and others involved and/or interested in the therapeutic management of patients with lung cancer.
Educational material updated... November 3, 2016.
Expiration of CME credit...May 3, 2017.
Financial Support...Merck.
After viewing Lung Immunotherapies: Shifting the Lung Cancer Treatment Paradigm, you will be better able to:
• Summarize the underlying principles for immunotherapeutic strategies taking into consideration lung cancer pathophysiology.
• Evaluate the safety and efficacy of available and emerging immunotherapies
• Determine if or when immunotherapy is appropriate in the first- and second-line settings for patients with metastatic NSCLC
• Address adverse events associated with immunotherapy in lung cancer

Updates in Lung Cancer: Targeting Epidermal Growth Factor Receptor
Live online September 7, 2016, and available on demand through March 7, 2017.
Posted by...Bernard Sklar, MD.Lung Cancer CME
Free Lung Cancer CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, oncology nurses, nurse practitioners, physician assistants, internists, primary care physicians, pulmonologists, and other health care professionals who treat patients with lung cancer.
Educational material updated... September 7, 2016.
Expiration of CME credit... March 7, 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc.
Updates in Lung Cancer: Targeting Epidermal Growth Factor Receptor consists of a single lecture:
• Updates in Lung Cancer: Targeting Epidermal Growth Factor Receptor
At the conclusion of Updates in Lung Cancer, you will be able to:
• Review the pathophysiology of NSCLC and the role played by EGFR and activating EGFR mutations
• Provide the rationale for EGFR mutation testing to identify appropriate patients for targeted therapy
• Evaluate currently approved EGFR inhibitors and their role in the treatment of NSCLC
• Discuss the adverse events common to this drug class and how individual drugs might differ, and present management strategies

Updates in Lung Cancer: ALK Inhibition in the Treatment of NSCLC Free Pulmonary CME
Live online September 7, 2016, and available on demand through March 7, 2017.
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists, radiation oncologists, lung surgeons, fellows and other health care professionals (primary care physicians, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with lung cancer.
Educational material updated...September 7, 2016.
Expiration of CME credit... March 7, 2017.
Financial Support...Ariad Pharmaceuticals, Inc.
At the conclusion of Updates in Lung Cancer: ALK Inhibition in the Treatment of NSCLC, you will be able to:
• Provide rationale for testing for ALK mutations and use of ALK inhibitors
• Evaluate latest clinical data on new and emerging ALK inhibitors and combinations for use in patients with NSCLC
• Manage resistance to ALK inhibitors with appropriate second-line options

Virtual Prostate Summit: Evolving Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer Prostate Cancer CME
Live online July 27, 2016, and available on demand through July 27, 2017.
Posted by...Bernard Sklar, MD.
Free Prostate Cancer CME Credit hours...2.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists, urologists, and health care professionals involved in the management of patients with prostate cancer, including those with metastatic castration-resistant prostate cancer.
Educational material updated... July 27, 2016.
Expiration of CME credit... July 27, 2017.
Financial Support...Sanofi US.
Evolving Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer consists of two lectures:
• Management of Metastatic Prostate Cancer - Non-Androgen Receptor-Targeted Therapies
• Androgen Receptor-Targeted Therapies - Metastatic Castration-resistant Prostate Cancer
At the conclusion of Evolving Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer, you will be able to:
• Address barriers to the optimal use of new therapies in patients with prostate cancer
• Evaluate relative safety, efficacy, and tolerability on therapeutic options for prostate cancer and potential sequencing combinations for those patients with suboptimal responses
• Identify and assess relative safety, efficacy, and tolerability on therapeutic options for metastatic castration-resistant prostate cancer

ScientiaCME Hematology/ Oncology  ScientiaCME Oncology  
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit Hours...7.25.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...HEMATOLOGY.
CME Credit Expires...Two years after release.
Financial Support...Various commercial supporters.

HER2+ BRCA INSTANT SYMPOSIUM: Updates on HER2 Positive Breast Cancer Management Free Breast Cancer CME
Live online June 10, 2016, and available on demand through June 10, 2017.
Posted by...Bernard Sklar, MD.
Free Breast Cancer CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, hematologist-oncologists, radiation oncologists, breast surgeons, oncology nurse practitioners, pharmacists, and other healthcare professionals who treat patients with breast cancer.
Educational material updated...June 10, 2016.
Expiration of CME credit...June 10, 2017.
Financial Support...Genentech.
Updates on HER2 Positive Breast Cancer Management consists of a single lecture with discussion:
Updates on HER2 Positive Breast Cancer Management
At the conclusion of Updates on HER2 Positive Breast Cancer Management, you will be able to:
• Summarize the efficacy and safety of new and emerging treatment approaches for HER2 positive breast cancer in the neoadjuvant, adjuvant and metastatic settings
• Evaluate therapeutic challenges associated with HER2-targeted treatment, including resistance, toxicity and optimal duration of treatment